2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
复制标题

DOI:
10.1161/cir.0b013e3182618569
复制
发表时间:
2012-10-02
期刊:
影响因子:
37.8
通讯作者:
Varosy, Paul D.
Varosy, Paul D.
中科院分区:
医学1区
文献类型:
--
作者:
Tracy, Cynthia M.;Epstein, Andrew E.;Varosy, Paul D.

文献摘要

被引文献

相似文献

1.1. 在ACC、AHA、HRS和欧洲心脏病学会(2008 - 2010)年度科学会议上发表的最新临床试验,以及截至2012年1月报告的其他精选数据,由指南撰写小组与工作组和其他专家共同审查,以确定可能影响指南推荐的试验和其他关键数据。基于之前提到的标准和考虑(序言),最近公布的试验数据和其他临床信息被认为非常重要,足以促使对“ACC/AHA/HRS 2008心律异常器械治疗指南”进行重点更新(4)。为了向临床医生提供一套全面的数据,指南中提供了绝对风险差异和治疗或伤害所需的数量,如果它们已发表并且被认为是适当的,以及与相对治疗效果相关的置信区间(ci)和数据,如优势比、相对风险比(RR)、危险比(HR)或发病率比。
1.1. Methodology and Evidence Review Late-breaking clinical trials presented at the annual scientific meetings of the ACC, AHA, HRS, and European Society of Cardiology (2008 through 2010), as well as other selected data reported through January 2012, were reviewed by the guideline writing group along with the Task Force and other experts to identify trials and other key data that might affect guideline recommendations. On the basis of the criteria and considerations noted previously (Preamble), recently published trial data and other clinical information were considered important enough to prompt a focused update of the “ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities”(4). To provide clinicians with a comprehensive set of data, the absolute risk difference and number needed to treat or harm, if they were published and their inclusion was deemed appropriate, are provided in the guideline, along with confidence intervals (CIs) and data related to the relative treatment effects, such as odds ratio, relative risk (RR), hazard ratio (HR), or incidence rate ratio.